Significant M&A Agreements Are On The Horizon For 2023
According to EY's 2023 M&A Firepower report, the life sciences sector has record levels of deal-making Firepower, which measures a company's ability to undertake...
A Breakthrough Medication For Dystonia Is Being Developed
Thousands of musicians now have hope after substantial progress was made in the search for a dystonia cure by a research team in Korea.
1–3%...
Australia Introduces A New Tool To Lower Medicine Costs
Millions of Australians will pay up to 29% less for their Pharmaceutical Benefits Scheme (PBS) prescriptions because the maximum PBS co-payment is going down...
Inflation Is Pharma Executives Top Challenge In 2023- Poll
According to a survey of executives done by GlobalData Healthcare, the pharmaceutical industry's top concern heading into 2023 is INFLATION.
The study, which was conducted...
Hong Kong University Creates Bone Anabolic Aptamer Drug
The molecular target for bone anabolic therapy has been discovered by a research team headed by Hong Kong Baptist University (HKBU), utilising a particular...
Cancer Treatment Rates In NHS Hit An All-Time High In 2022
The NHS has released encouraging statistics regarding cancer rates in the UK to kick off the new year. Over the past year, more patients...
Persistent Bacteria Are Undermining Antibiotic Treatment
Researchers from Uppsala University in Sweden have released a study on how various antibiotic treatments affect different types of bacteria and how they respond...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...